When comparing HOXA11 methylation level to clinical features, we noticed a significant higher incidence of hypermethylation in invasive ductal carcinomas (IDCs), patients with a family history of cancer, cases with metastatic lymph nodes and P53 positive group than their counterparts. The gene discussed is TP53; the disease is invasive ductal breast carcinoma.